基本资料 投资组合 财务数据 基金公告
汇添富纳斯达克生物科技ETF(QDII)(513290) |
净值：
1.4253
|
日增长率：
2.97%
|
累计净值：1.4253 | 2025-11-11 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| VRTX | 福泰制药 | 37,096.00 | 103,230,675.35 | 7.76 |
| GILD | 吉利德科学 | 128,399.00 | 101,269,639.49 | 7.62 |
| AMGN | 安进 | 50,416.00 | 101,092,756.59 | 7.60 |
| ALNY | Alnylam Pharmaceuticals Inc | 22,787.00 | 73,832,341.00 | 5.55 |
| REGN | 再生元制药 | 18,109.00 | 72,349,248.56 | 5.44 |
| AZN | 阿斯利康(US ADR) | 90,772.00 | 49,482,899.82 | 3.72 |
| INSM | Insmed Inc | 37,051.00 | 37,912,919.45 | 2.85 |
| ARGX | argenx SE ADR | 5,366.00 | 28,121,771.02 | 2.11 |
| BIIB | 生化基因 | 25,699.00 | 25,579,202.57 | 1.92 |
| UTHR | 联合治疗 | 7,927.00 | 23,612,128.38 | 1.78 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2025-09-30 | 87.09 | - | 0.75 | 1,329,766,618.46 |
| 2025-06-30 | 85.33 | - | 0.68 | 1,276,255,394.75 |
| 2025-03-31 | 86.03 | - | 0.63 | 1,345,089,030.94 |
| 2024-12-31 | 87.93 | - | 0.91 | 1,527,169,600.76 |
| 2024-09-30 | 87.03 | - | 0.96 | 1,360,481,855.81 |
微信公众号
证券之星APP
